Bausch + Lomb Corporation (BLCO) Stock

Bausch + Lomb Corporation, a global leader in eye health, operates internationally with a focus on enhancing vision and eye care.

The company's operations are structured into three key segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. Within the Vision Care/Consumer Health Care segment, Bausch + Lomb offers a comprehensive range of contact lenses, including daily disposables and specialized lenses, alongside a variety of contact lens care products, over-the-counter eye drops, and nutritional supplements tailored to address diverse eye conditions such as allergies, conjunctivitis, and dry eye.

Bausch + Lomb's Ophthalmic Pharmaceuticals segment is dedicated to developing and distributing both proprietary and generic pharmaceuticals designed for post-operative care and treatment of ocular conditions like glaucoma, ocular hypertension, and retinal diseases. The segment also provides therapeutic contact lenses. Meanwhile, the Surgical segment focuses on advanced tools and technologies for cataract treatment, as well as vitreous and retinal conditions. Its offerings include intraocular lenses, phacoemulsification equipment, and a range of surgical instruments and devices crucial for ophthalmic procedures.

Established in 1853 and headquartered in Vaughan, Canada, Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc., continuing its legacy of innovation and commitment to improving vision health worldwide.